Academician Gao Fu won two honorary titles. What contribution has he made to epidemic prevention and control?
He is a pioneer in product development, the first COVID-19 neutralizing antibody and the first recombinant COVID-19 protein vaccine approved for clinical application in the world. Gao Fu has brought the key scientific and reasonable basis for the country to formulate the current bird flu epidemic prevention and control policy, and led the first batch of mobile laboratory testing teams of China Center for Disease Control and Prevention to fight Ebola in Sierra Leone, which inspired the leading role of international assistance.